26 research outputs found
Incontinentia Pigmenti
Incontinentia pigment! (Bloch-Sulzberger syndrome) is a rare neuroectodermal dysptasia. It is an X-linked dominant disorder caused by mutations in the IKBKG/NEMO gene on Xq28. Approximately 80% of patients have a deletion of exons 4 to 10. Incontinentia pigmenti has an estimated incidence of 0.7 cases per 100,000 births. In hemizygous males, it is usually lethal, while in females, it has a wide spectrum of clinical manifestations. Incontinentia pigmenti is a muttisystemic disease that invariably features skin changes. These changes are the main diagnostic criteria and they evolve in 4 stages, in association with other abnormalities affecting the central nervous system, eyes, teeth, mammary glands, hair, nails, skin, and other parts of the body. The aim of this brief review is to highlight the clinical features of this genodermatosis and underline the importance of case-by-case interdisciplinary management, including genetic counseling. (C) 2018 AEDV. Published by Elsevier Espana, S.L.U. All rights reserved
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Interindividual clinical variability in the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is vast. We report that at least 101 of 987 patients with life-threatening coronavirus disease 2019 (COVID-19) pneumonia had neutralizing immunoglobulin G (IgG) autoantibodies (auto-Abs) against interferon-w (IFN-w) (13 patients), against the 13 types of IFN-a (36), or against both (52) at the onset of critical disease; a few also had auto-Abs against the other three type I IFNs. The auto-Abs neutralize the ability of the corresponding type I IFNs to block SARS-CoV-2 infection in vitro. These auto-Abs were not found in 663 individuals with asymptomatic or mild SARS-CoV-2 infection and were present in only 4 of 1227 healthy individuals. Patients with auto-Abs were aged 25 to 87 years and 95 of the 101 were men. A B cell autoimmune phenocopy of inborn errors of type I IFN immunity accounts for life-threatening COVID-19 pneumonia in at least 2.6% of women and 12.5% of men
Apoptotic activity induced by the mycotoxins ochratoxin A and zearalenone in bovine lymphocytes
Ochratoxin A (OTA) and zearalenone (ZEA) are fungal metabolites which contaminate animal and human food. They have been found in cow’s meat and milk and several reports indicated that OTA was immunosuppressive, carcinogenic and teratogenic in animals (Hussein and Brasel, 2001; Creppy, 2002). On the other hand, ZEA and its metabolites have estrogenic and anabolic activities, being able to cause alterations in the reproductive tract of laboratory animals (Creppy, 2002) and dairy cattle, and having negative effects on meiotic progression of bovine oocytes (Minervini et al, 2001). The mechanisms by which OTA and ZEA damage the cells are not completely understood; recent results evidenced that OTA induces apoptosis in MDCK-C7 cells.........
Transcript level of NF-Kappa-B inhibitor alpha (IkBa) is regulated during mammalian meiosis.
NESCA: A new NEMO/IKKgamma and TRAF6 interacting protein.
NEMO/IKKgamma is the essential regulatory subunit of the IkB Kinase (IKK) complex, required for the activation of Nuclear Factor kB (NF-kB) in many physiological processes such as inflammation, immunity, apoptosis, or development. NEMO works at a converging point of the NF-kB pathway as it interacts with upstream signaling molecules to orchestrate its activation. Here we report on the identification of a novel NEMO-interacting protein, NESCA, an adapter molecule previously shown to be involved in the NGF-pathway via the TrkA receptor. We demonstrated that NESCA and NEMO interact by their N-terminal region. Beside to NEMO, we revealed that NESCA directly associates to the E3 ubiquitin ligase TRAF6, which in turn catalyzes NESCA polyubiquitination. Finally, we demonstrated that NESCA overexpression strongly inhibits TRAF6-mediated polyubiquitination of NEMO. In summary, our results highlight that NESCA represents a novel missing link in the NEMO-mediated NF-kB activation pathway